Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Neuropsychopharmacology

Journal
uri icon
  • Overview
  • Identity
  • View All
scroll to property group menus

Overview

articles

  • Validation of a nicotine vapor self-administration model in rats with relevance to electronic cigarette use 2020
  • A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology 2020
  • Activation of peroxisome proliferator-activated receptor gamma reduces alcohol drinking and seeking by modulating multiple mesocorticolimbic regions in rats 2020
  • Insula to ventral striatal projections mediate compulsive eating produced by intermittent access to palatable food.  45:579-588. 2020
  • A G protein signaling-biased agonist at the μ-opioid receptor reverses morphine tolerance while preventing morphine withdrawal.  45:416-425. 2020
  • Promoting activity of (α4)3(β2)2 nicotinic cholinergic receptors reduces ethanol consumption.  45:301-308. 2020
  • Targeting persistent stress-enhanced memory through microRNAs 2020
  • Conjugate vaccine produces long-lasting attenuation of fentanyl vs. food choice and blocks expression of opioid withdrawal-induced increases in fentanyl choice in rats.  44:1681-1689. 2019
  • Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion.  44:939-949. 2019
  • Synaptic adaptations in the central amygdala and hypothalamic paraventricular nucleus associated with protracted ethanol abstinence in male rhesus monkeys.  44:982-993. 2019
  • Homeostatic cAMP regulation by the RGS7 complex controls depression-related behaviors.  44:642-653. 2019
  • Unique treatment potential of cannabidiol for the prevention of relapse to drug use.  44:229-229. 2019
  • Knockdown of hypocretin attenuates extended access of cocaine self-administration in rats.  43:2373-2382. 2018
  • Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle.  43:2036-2045. 2018
  • Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intake.  43:1840-1850. 2018
  • Dynorphin counteracts orexin in the paraventricular nucleus of the thalamus: cellular and behavioral evidence.  43:1010-1020. 2018
  • Compulsive-like sufentanil vapor self-administration in rats.  43:801-809. 2018
  • Clinical and preclinical evidence for functional interactions of cannabidiol and Δ9-tetrahydrocannabinol.  43:142-154. 2018
  • High-frequency stimulation of the subthalamic nucleus blocks compulsive-like re-escalation of heroin taking in rats.  42:1850-1859. 2017
  • Genetic deletion of the nociceptin/orphanin FQ receptor in the rat confers resilience to the development of drug addiction.  42:695-706. 2017
  • Dissecting suicidality using a combined genomic and clinical approach.  42:360-361. 2017
  • Locomotor Stimulant and Rewarding Effects of Inhaling Methamphetamine, MDPV, and Mephedrone via Electronic Cigarette-Type Technology.  41:2759-2771. 2016
  • Double dissociation of monoacylglycerol lipase inhibition and CB1 antagonism in the central amygdala, basolateral amygdala, and the interoceptive insular cortex on the affective properties of acute naloxone-precipitated morphine withdrawal in rats.  41:1865-1873. 2016
  • 5-HT1A autoreceptors in the dorsal raphe nucleus convey vulnerability to compulsive cocaine seeking.  41:1210-1222. 2016
  • Dynorphin, Dysphoria, and Dependence: the Stress of Addiction.  41:373-374. 2016
  • Pharmacological selectivity within class I histone deacetylases predicts effects on synaptic function and memory rescue.  40:2307-2316. 2015
  • Hypocretin receptor 2 antagonism dose-dependently reduces escalated heroin self-administration in rats.  40:1123-1129. 2015
  • Compulsive-like responding for opioid analgesics in rats with extended access.  40:421-428. 2015
  • Chronic treatment with novel brain-penetrating selective NOP receptor agonist MT-7716 reduces alcohol drinking and seeking in the rat.  39:2601-2610. 2014
  • Transient receptor potential vanilloid type 1 channel may modulate opioid reward.  39:2414-2422. 2014
  • Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling.  39:1763-1776. 2014
  • Phosphodiesterase 10A regulates alcohol and saccharin self-administration in rats.  39:1722-1731. 2014
  • Nociceptin/orphanin FQ decreases glutamate transmission and blocks ethanol-induced effects in the central amygdala of naive and ethanol-dependent rats.  39:1081-1092. 2014
  • The development and maintenance of drug addiction.  39:254-262. 2014
  • Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala.  38:2498-2507. 2013
  • Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporter.  38:2170-2178. 2013
  • Inactivation of JAK2/STAT3 Signaling Axis and Downregulation of M1 mAChR Cause Cognitive Impairment in klotho Mutant Mice, a Genetic Model of Aging.  38:1426-1437. 2013
  • Dual inhibition of endocannabinoid catabolic enzymes produces enhanced antiwithdrawal effects in morphine-dependent mice.  38:1039-1049. 2013
  • The NK1 receptor antagonist l822429 reduces heroin reinforcement.  38:976-984. 2013
  • The volitional nature of nicotine exposure alters anandamide and oleoylethanolamide levels in the ventral tegmental area.  38:574-584. 2013
  • Ghrelin increases gabaergic transmission and interacts with ethanol actions in the rat central nucleus of the amygdala.  38:364-375. 2013
  • Molecular, cellular, and structural mechanisms of cocaine addiction: a key role for microRNAs.  38:198-211. 2013
  • Robust escalation of nicotine intake with extended access to nicotine self-administration and intermittent periods of abstinence.  37:2153-2160. 2012
  • A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults.  37:1689-1698. 2012
  • Levels of neural progenitors in the hippocampus predict memory impairment and relapse to drug seeking as a function of excessive methamphetamine self-administration.  37:1275-1287. 2012
  • Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effects.  37:1083-1091. 2012
  • R7BP modulates opiate analgesia and tolerance but not withdrawal.  37:1005-1012. 2012
  • Enhanced sensitivity to attenuation of conditioned reinstatement by the mGluR 2/3 agonist LY379268 and increased functional activity of mGluR 2/3 in rats with a history of ethanol dependence.  36:2762-2773. 2011
  • Genetic association of recovery from eating disorders: The role of gaba receptor snps.  36:2222-2232. 2011
  • Activation of σ-receptors induces binge-like drinking in Sardinian alcohol-preferring rats.  36:1207-1218. 2011
  • The endocannabinoid system tonically regulates inhibitory transmission and depresses the effect of ethanol in central amygdala.  35:1962-1972. 2010
  • Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances.  35:1761-1774. 2010
  • FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.  35:1775-1787. 2010
  • Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease.  35:870-880. 2010
  • R7BP complexes with RGS9-2 and RGS7 in the striatum differentially control motor learning and locomotor responses to cocaine.  35:1040-1050. 2010
  • Convergent functional genomics: what we have learned and can learn about genes, pathways, and mechanisms.  35:355-356. 2010
  • Neurocircuitry of addiction.  35:217-238. 2010
  • Reduced expression of the NMDA receptor-interacting protein SynGAP causes behavioral abnormalities that model symptoms of schizophrenia.  34:1659-1672. 2009
  • The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking.  34:1482-1493. 2009
  • Antidepressants influence somatostatin levels and receptor pharmacology in brain.  34:952-963. 2009
  • Nmda receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: Role of the ventral tegmental area and central nucleus of the amygdala.  34:266-281. 2009
  • Disruption of the CRF(2) receptor pathway decreases the somatic expression of opiate withdrawal.  33:2878-2887. 2008
  • Attenuation of cue-induced heroin-seeking behavior by cannabinoid CB(1) antagonist infusions into the nucleus accumbens core and prefrontal cortex, but not basolateral amygdala.  33:2483-2493. 2008
  • Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments.  33:2474-2482. 2008
  • Rats with extended access to cocaine exhibit increased stress reactivity and sensitivity to the anxiolytic-like effects of the mGluR 2/3 agonist LY379268 during abstinence.  33:1818-1826. 2008
  • The dorsal subiculum mediates the acquisition of conditioned reinstatement of cocaine-seeking.  33:1827-1834. 2008
  • Genetic regulation of behavioral and neuronal responses to fluoxetine.  33:1312-1322. 2008
  • Opioid-dependent anticipatory negative contrast and binge-like eating in rats with limited access to highly preferred food.  33:524-535. 2008
  • Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.  33:643-652. 2008
  • Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders.  33:312-319. 2008
  • Subchronic cannabinoid agonist (WIN 55,212-2) treatment during cocaine abstinence alters subsequent cocaine seeking behavior.  32:2260-2266. 2007
  • Effect of aripiprazole, a partial dopamine d-2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration.  32:2238-2247. 2007
  • Differential effects of sigma(1) receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward.  32:1967-1973. 2007
  • Role of endocannabinoids in alcohol consumption and intoxication: Studies of mice lacking fatty acid amide hydrolase.  32:1570-1582. 2007
  • Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: Intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.  32:1052-1068. 2007
  • Fg 7142 specifically reduces meal size and the rate and regularity of sustained feeding in female rats: Evidence that benzodiazepine inverse agonists reduce food palatability.  32:1069-1081. 2007
  • Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task.  32:1032-1041. 2007
  • Behavioral and neurochemical responses to cocaine in periadolescent and adult rats.  32:625-637. 2007
  • Impact of ambient temperature on hyperthermia induced by (+/-)3,4-methylenedioxymethamphetamine in rhesus macaques.  32:673-681. 2007
  • Big dynorphin, a prodynorphin-derived peptide produces nmda receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice.  31:1928-1937. 2006
  • Dissociation of analgesic and hormonal responses to forced swim stress using opioid receptor knockout mice.  31:1733-1744. 2006
  • Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity.  31:1203-1211. 2006
  • Chronic ethanol exposure and protracted abstinence alter nmda receptors in central amygdala.  31:988-996. 2006
  • Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathway.  31:804-813. 2006
  • A reduced rate of in vivo dopamine transporter binding is associated with lower relative reinforcing efficacy of stimulants.  31:351-362. 2006
  • Unlimited access to heroin self-administration: Independent motivational markers of opiate dependence.  31:2692-2707. 2006
  • Comt polymorphisms and anxiety-related personality traits.  30:2092-2102. 2005
  • Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala.  30:497-507. 2005
  • Modeling human methamphetamine exposure in nonhuman primates: chronic dosing in the rhesus macaque leads to behavioral and physiological abnormalities.  30:350-359. 2005
  • Buprenorphine and a crf1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.  30:90-98. 2005
  • Previous exposure to psychostimulants enhances the reinstatement of cocaine seeking by nucleus Accumbens AMPA.  29:2149-2159. 2004
  • Presynaptic modulation of spontaneous inhibitory postsynaptic currents by gamma-hydroxybutyrate in the substantia nigra pars compacta.  29:537-543. 2004
  • Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats.  28:1463-1471. 2003
  • Previous exposure to VTA amphetamine enhances cocaine self-administration under a progressive ratio schedule in an NMDA, AMPA/kainate, and metabotropic glutamate receptor-dependent manner.  28:629-639. 2003
  • Inhibition of 5-ht neurotransmission increases clonidine protective effects on naloxone-induced conditioned place aversion in morphine-dependent rats.  28:276-283. 2003
  • Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge.  27:993-1005. 2002
  • Gamma-hydroxybutyrate reduces gaba(a)-mediated inhibitory postsynaptic potentials in the ca1 region of hippocampus.  27:960-969. 2002
  • Previous exposure to VTA amphetamine enhances cocaine self-administration under a progressive ratio schedule in a D1 dopamine receptor dependent manner.  27:970-979. 2002
  • A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone.  27:596-606. 2002
  • Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats.  27:391-399. 2002
  • Conditioned opioid withdrawal decreases nociceptin/orphanin cortex and olfactory fq levels in the frontal cortex and olfactory tubercle.  27:203-211. 2002
  • Effect of bilateral 6-hydroxydopamine lesions of the medial forebrain bundle on reaction time.  26:756-764. 2002
  • Involvement of the sigma(1) receptor in cocaine-induced conditioned place preference: Possible dependence on dopamine uptake blockade.  26:444-455. 2002
  • Extended radioligand binding profile of iloperidone: A broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders.  25:904-914. 2001
  • Dopamine partial agonist reverses amphetamine withdrawal in rats.  25:789-792. 2001
  • Enduring resistance to extinction of cocaine-seeking behavior induced by drug-related cues.  25:361-372. 2001
  • Anxiogenic-like effects limit rewarding effects of cocaine in balb/cbyj mice.  24:300-318. 2001
  • Functional consequences of repeated (+/-)3,4-methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys.  24:230-239. 2001
  • Drug addiction, dysregulation of reward, and allostasis.  24:97-129. 2001
  • Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion.  24:152-160. 2001
  • N-[1-(2-benzo[b]thiophenyl)Cyclohexyl]- piperidine (BTCP) exerts cocaine-like actions on drug-maintained responding in rats.  23:316-325. 2000
  • Excessive ethanol drinking following a history of dependence: Animal model of allostasis.  22:581-594. 2000
  • Persistent increase in the motivation to take heroin in rats with a history of drug escalation.  22:413-421. 2000
  • Behavioral effects of central administration of the novel crf antagonist astressin in rats.  22:230-239. 2000
  • Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat.  20:471-479. 1999
  • Determinants of P3 amplitude and response to alcohol in Native American Mission Indians.  18:282-292. 1998
  • Neurobiological similarities in depression and drug dependence: A self-medication hypothesis.  18:135-174. 1998
  • Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats.  18:125-133. 1998
  • Clonidine blocks acquisition but not expression of conditioned opiate withdrawal in rats.  19:406-416. 1998
  • Electrophysiological actions of neuropeptide Y and its analogs: New measures for anxiolytic therapy?.  17:34-43. 1997
  • Antistress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity.  11:179-186. 1994
  • Anxiolytic-like action of neuropeptide-y - mediation by y1 receptors in amygdala, and dissociation from food-intake effects.  8:357-363. 1993
  • Lisuride reduces psychomotor retardation during withdrawal from chronic intravenous amphetamine self-administration in rats.  8:213-218. 1993
  • Selective effects of low-dose d2-dopamine receptor antagonism in a reaction-time-task in rats.  8:195-200. 1993
  • Rapid induction of conditioned opiate withdrawal in the rat.  8:15-21. 1993
  • Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal.  7:213-224. 1992
  • Nonlinear-analysis of EEG sleep states.  5:167-176. 1991
  • Endocrine, immune, and neurochemical changes in rats during withdrawal from chronic amphetamine intoxication.  5:23-31. 1991
  • Evaluation of EEG alpha-activity in sons of alcoholics.  4:199-205. 1991
  • Postcocaine anhedonia: an animal model of cocaine withdrawal.  4:17-26. 1991
  • Bromocriptine produces decreases in cocaine self-administration in the rat.  3:101-108. 1990
  • Potentiation of acoustic startle by corticotropin-releasing factor (crf) and by fear are both reversed by alpha-helical crf (9-41).  2:285-292. 1989
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0893-133X

Electronic International Standard Serial Number (EISSN)

  • 1740-634X

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support